Literature DB >> 19013877

Comparative analysis of D2-40 and LYVE-1 immunostaining in lymphatic malformations.

A Florez-Vargas1, S O Vargas, L V Debelenko, A R Perez-Atayde, T Archibald, H P W Kozakewich, D Zurakowski.   

Abstract

Identification of lymphatic vessels in normal tissue and vascular malformations has been considerably enhanced by the recently discovered lymphatic endothelial markers D2-40 and LYVE-1. However, comparative analysis of these two antibodies in the evaluation of lymphatic malformations has not been widely reported. We evaluated twenty lymphatic malformations of skin/subcutis/soft tissue with immunostaining for D2-40 and LYVE-1. Ten high-power fields from each section were scored for total number of immunopositive vessels using identical fields with both markers. Vessels were grouped by diameter (< 225 microm and > 225 microm), with each vessel categorized according to the percentage of its lumen showing immunopositivity (< 25, 26-75, or > 75). Endothelial staining intensity was graded low or high in each case. We found no significant difference between total number of vessels stained with D2-40 or LYVE-1 or between the 2 markers in terms of the percentage of luminal circumference stained or intensity in vessels smaller than 225 microm. LYVE-1 stained a higher percentage of luminal circumference of channels greater than 225 microm at both low and high intensities. Large channels stained much less and sometimes not at all with either antibody. D2-40 and LYVE-1 are both effective for highlighting endothelium of lymphatic malformations, staining similar percentages of channels. LYVE-1 provides more luminal staining in channels larger than 225 microm but is less specific also staining macrophages and adipocytes. Both markers are expressed less strongly or sometimes not at all in large channels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013877

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  10 in total

1.  Toward an understanding of lymphatic malformations.

Authors:  Adam M Vogel; Brad W Warner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

2.  Isolation of human lymphatic endothelial cells by multi-parameter fluorescence-activated cell sorting.

Authors:  Zerina Lokmic; Elizabeth S Ng; Matthew Burton; Edouard G Stanley; Anthony J Penington; Andrew G Elefanty
Journal:  J Vis Exp       Date:  2015-05-01       Impact factor: 1.355

3.  A novel method for isolating lymphatic endothelial cells from lymphatic malformations and detecting PIK3CA somatic mutation in these isolated cells.

Authors:  Hidehito Usui; Yoshinori Tsurusaki; Hiroko Shimbo; Hirotomo Saitsu; Noriaki Harada; Norihiko Kitagawa; Kyoko Mochizuki; Munetaka Masuda; Kenji Kurosawa; Masato Shinkai
Journal:  Surg Today       Date:  2020-09-02       Impact factor: 2.549

4.  Vascular lesions of bone in children, adolescents, and young adults. A clinicopathologic reappraisal and application of the ISSVA classification.

Authors:  Elisabeth Bruder; Antonio R Perez-Atayde; Gernot Jundt; Ahmad I Alomari; Johannes Rischewski; Steven J Fishman; John B Mulliken; Harry P W Kozakewich
Journal:  Virchows Arch       Date:  2008-12-24       Impact factor: 4.064

Review 5.  Pediatric lymphatic malformations: evolving understanding and therapeutic options.

Authors:  Ann M Defnet; Naina Bagrodia; Sonia L Hernandez; Natalie Gwilliam; Jessica J Kandel
Journal:  Pediatr Surg Int       Date:  2016-01-27       Impact factor: 1.827

6.  Engineering Blood and Lymphatic Microvascular Networks in Fibrin Matrices.

Authors:  Lea Knezevic; Mira Schaupper; Severin Mühleder; Katharina Schimek; Tobias Hasenberg; Uwe Marx; Eleni Priglinger; Heinz Redl; Wolfgang Holnthoner
Journal:  Front Bioeng Biotechnol       Date:  2017-04-18

7.  HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3.

Authors:  Tao Han; Jun Yan; Haini Chen; Yi Ji; Jianbing Chen; Jie Cui; Weimin Shen; Jijun Zou
Journal:  Int J Oncol       Date:  2018-11-05       Impact factor: 5.884

Review 8.  Kaposiform hemangioendothelioma: current knowledge and future perspectives.

Authors:  Yi Ji; Siyuan Chen; Kaiying Yang; Chunchao Xia; Li Li
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

9.  Results of Injection Sclerotherapy with Bleomycin in Pediatric Lymphatic Malformations.

Authors:  Vipan Kumar; Subhasis Roy Choudhury; Partap Singh Yadav; Vikram Khanna; Amit Gupta; Rajiv Chadha; Rama Anand
Journal:  J Indian Assoc Pediatr Surg       Date:  2021-07-12

10.  Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles.

Authors:  Qiu Guo; Yi Liu; Ke Xu; Ke Ren; WenGe Sun
Journal:  Int J Nanomedicine       Date:  2013-06-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.